Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × cabozantinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 14 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Osteosarcoma 3 Melanoma 3 Clear-cell metastatic renal cell carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Brain Neoplasms 2 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Kaposi 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Mouth Neoplasms 1

Interventions

Specimen Handling 7 Biopsy 6 ruxolitinib 2 fludarabine 2 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fedratinib 1 axatilimab 1 Topotecan 1 Tacrolimus 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡